MSB 0.42% $1.18 mesoblast limited

This is my first post in almost a year (likemany, having seen a...

  1. 118 Posts.
    lightbulb Created with Sketch. 113

    This is my first post in almost a year (likemany, having seen a significant unrealised profit evaporate, the day the ARDStrial was stopped).

    I went off into the wilderness to lick my wounds and contemplate what couldhave been.

    I have however, maintained my holding and continue to read the MSBposts on HC and YH.

    I now have a question that I’m hoping oneof the resident experts can answer.

    When I initially read the 4C document on Friday Morning one word stood out “appropriateness”(see the extract below).

    Does this mean that SI/MSB are questioning the need or relevance of potencyassays relating to Rem-L and how does this relate to the what the FDA haveasked regarding “potency assays”?

    I looked up the definition of “potency assays”
    (the quantitative measure of biologicalactivity)to see if thiswould help answer my question (it didn't).

    Have I misunderstood/misinterpreted the statement?

    https://hotcopper.com.au/data/attachments/3744/3744148-ad312829c836d98f04d40f92aed08e41.jpg


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
-0.005(0.42%)
Mkt cap ! $1.341B
Open High Low Value Volume
$1.18 $1.20 $1.14 $10.44M 8.934M

Buyers (Bids)

No. Vol. Price($)
3 45750 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 1476 1
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
$1.18
  Change
-0.005 ( 0.31 %)
Open High Low Volume
$1.18 $1.20 $1.14 1465927
Last updated 15.59pm 24/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.